시장보고서
상품코드
1555086

세계의 호흡 회로 시장 : 사용법별, 환자 유형별, 회로 유형별, 용도별, 최종 사용자별, 지역별 예측(-2029년)

Breathing Circuits Market by Circuit Type (Single Limb, Dual Limb), Usage (Disposable, Reusable), Application (Anesthesia, Respiratory Dysfunction), Patient Type (Adults, Pediatric & Neonatal), End User (Hospitals, Clinics) - Global Forecast to 2029

발행일: | 리서치사: MarketsandMarkets | 페이지 정보: 영문 282 Pages | 배송안내 : 즉시배송

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

호흡 회로 시장 규모는 2024년 15억 7,000만 달러에서 2029년 21억 6,000만 달러로 성장할 것으로 예측되며, 예측 기간 중 CAGR은 6.5%가 될 것으로 보입니다.

호흡 회로 기술의 향상은 시장의 주요 촉진요인 중 하나입니다. 지난 2-3년 동안 안전성, 쾌적성, 효율성 중심 개발을 강화하기 위해 취해진 새로운 노력과 노력으로 호흡회로는 점차 정교하고 효율적인 형태가 되고 있습니다. 예를 들어, 내장 가습, 항균 필터 및 고급 인체공학적 설계를 특징으로 하는 호흡 회로는 감염과 불편함을 줄이면서 호흡 지원을 제공하는 데 더 큰 효과를 제공합니다. 또한 생산에 사용되는 고급 재료로 호흡 회로는 생체 적합성과 내성이 더 높습니다. 다양한 주요 기업들에 의한 이러한 기술적 진보는 호흡회로의 채택 확대로 이어져 향후 수년간 시장 성장을 가속할 것입니다.

조사 범위
조사 대상년도 2022-2029년
기준년 2023년
예측 기간 2024-2029년
검토 단위 금액(달러)
부문별 사용법별, 환자 유형별, 회로 유형별, 용도별, 최종 사용자별, 지역별
대상 지역 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카, GCC 국가

환자 유형별로 호흡 회로 시장은 성인 환자와 소아·신생아 환자로 이분됩니다. 예측 기간 동안 CAGR이 가장 높을 것으로 예측되는 것은 성인 환자 부문입니다. 이 환자 부문의 성장은 성인 수술, 특히 마취와 호흡 지원에 호흡 회로가 필요한 복잡하고 위험한 경우의 비율이 증가하고 있기 때문입니다. 또한, 인구 고령화와 COPD, 천식, 수면 무호흡 증후군과 같은 만성 호흡기 질환의 유병률 증가는 특히 수술에서 고급 호흡 회로의 사용과 관련이 있으며, 이는이 부문 성장을 더욱 밀어줍니다. 게다가, 앉지 않은 생활, 식생활의 흐트러짐, 흡연도 이러한 증상의 주요한 원인으로서 작용하기 위해, 성인의 호흡기 질환의 관리·치료에 있어서의 고도의 호흡 회로 수요를 증대시키고 있습니다.

호흡 회로 시장은 회로 유형별로 한쪽 다리 호흡 회로와 양지 호흡 회로로 구분됩니다. 이중 사지식 호흡 회로는 예측 기간 동안 가장 높은 CAGR을 차지할 것으로 예측됩니다. 이중 팔다리 호흡 회로는 중요하고 특수한 의료 용도에 많은 이점을 제공하기 때문에 큰 수요가 예상됩니다. 주요 요인 중 하나는 흡기와 호기를 위한 두 개의 다른 제어 채널을 제공하여 호기 이산화탄소의 재호흡을 방지하여 환기 효율을 높입니다. 이는 환자의 안전과 최적의 호흡 지원을 보장하기 위해 가스 관리를 올바르게 수행하는 것이 중요한 ICU와 OT에서 매우 중요할 것으로 보입니다. 이중 사지 회로의 또 다른 장점은 가습기, 필터, 모니터 장치 등의 액세서리를 장착하여 환자에게 적절하고 종합적인 관리를 촉진할 수 있다는 점입니다. 이 외에도 이러한 회로는 다양한 환자와 다양한 의료 개입에 적응할 수 있으므로 건강 관리의 적용 가능성이 더욱 높아진다는 사실도 있습니다.

본 보고서에서는 세계의 호흡 회로 시장에 대해 조사했으며, 사용법별, 환자 유형별, 회로 유형별, 용도별, 최종 사용자별, 지역별 동향 및 시장 진출기업 프로파일 등을 정리했습니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 중요 인사이트

제5장 시장 개요

  • 소개
  • 시장 역학
  • 가격 분석
  • 특허 분석
  • 밸류체인 분석
  • 공급망 분석
  • 무역 분석
  • 생태계 분석
  • Porter's Five Forces 분석
  • 주요 이해관계자와 구매 기준
  • 규제 분석
  • 기술 분석
  • 2024-2025년의 주된 회의와 이벤트
  • 고객사업에 영향을 주는 동향/혼란
  • 투자와 자금조달 시나리오
  • AI/생성형 AI가 호흡 회로 시장에 미치는 영향

제6장 호흡 회로 시장(사용법별)

  • 소개
  • 일회용형 호흡 회로
  • 재사용형 호흡 회로

제7장 호흡 회로 시장(환자 유형별)

  • 소개
  • 성인 환자
  • 소아 및 신생아 환자

제8장 호흡 회로 시장(회로 유형별)

  • 소개
  • 단지 호흡 회로
  • 양지 호흡 회로

제9장 호흡 회로 시장(용도별)

  • 소개
  • 마취
  • 호흡기능장애
  • 기타

제10장 호흡 회로 시장(최종사용자별)

  • 소개
  • 병원
  • 외래수술센터(ASC)
  • 클리닉
  • 기타

제11장 호흡 회로 시장(지역별)

  • 소개
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카
  • GCC 국가

제12장 경쟁 구도

  • 소개
  • 주요 진입기업의 전략/비책
  • 수익 분석(2021-2023년)
  • 시장 점유율 분석, 2023년
  • 기업평가 매트릭스: 주요 진입기업, 2023년
  • 기업평가 매트릭스: 스타트업/중소기업, 2023년
  • 기업가치평가와 재무지표
  • 브랜드/제품 비교
  • 경쟁 시나리오

제13장 기업 프로파일

  • 주요 진출기업
    • DRAGERWERK AG & CO. KGAA
    • MEDTRONIC
    • CARDINAL HEALTH
    • FISHER & PAYKEL HEALTHCARE LIMITED
    • RESMED
    • AMBU A/S
    • GE HEALTHCARE
    • KONINKLIJKE PHILIPS NV
    • ICU MEDICAL, INC.
    • HAMILTON MEDICAL
    • MEDLINE INDUSTRIES, LP
  • 기타 기업
    • FORCA HEALTHCARE
    • BRAUN & CO. LIMITED
    • INSPIRATION HEALTHCARE GROUP PLC
    • BESMED HEALTH BUSINESS CORP.
    • EAKIN HEALTHCARE
    • BOMIMED
    • FLEXICARE(GROUP) LIMITED
    • BIO-MED DEVICES
    • AIRLIFE
    • MERCURY MEDICAL
    • INTERSURGICAL LTD.
    • FAIRMONT MEDICAL PRODUCTS PTY LTD.
    • BREAS MEDICAL AB
    • GPC MEDICAL LTD.

제14장 부록

JHS 24.09.24

The breathing circuits market is expected to grow to USD 2.16 billion by 2029 from an estimated USD 1.57 billion in 2024, at a CAGR of 6.5% during the forecast period. Improvements in breathing circuit technology is one of the major drivers of the market. Within the past couple of years, new initiatives and efforts taken towards enhancing safety, comfort, and efficiency-oriented development have resulted in increasingly sophisticated and efficient forms of breathing circuits. For instance, breathing circuits that feature inbuilt humidification, antimicrobial filters, and advanced ergonomic designs have added to a much greater effect in delivering respiratory support while reducing infections and discomfort. Moreover, with advanced materials used in production, breathing circuits become more biocompatible and resistant. Such technological advancements by different key players will lead to increased adoption of breathing circuits, thus driving the market growth in the coming years.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD)
SegmentsBy Usage, Patient Type, Circuit Type, Application, and End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries

"Adult patients segment accounted for the highest growth rate in the breathing circuits market, by patient type, during the forecast period."

Based on patient type, the breathing circuits market is bifurcated into adult patients and pediatric and neonatal patients. The adult patients segment expected to have the highest CAGR during the forecast period. The growth in this patient segment is driven by the increasing rate of adult surgical interventions, especially complex and high-risk cases needing breathing circuits for anesthesia and respiratory support. Furthermore, the aging population and rising prevalence of chronic respiratory disorders, such as COPD, asthma, and sleep apnea, are often associated with the use of advanced breathing circuits, especially in surgical procedures, which further support this segment's growth. Moreover, sedentary life, poor diet, and smoking act also as major contributory factors to such conditions and hence increase the demand for advanced breathing circuits in managing and treating respiratory diseases in adults.

"Dual-limb Breathing Circuits segment is expected to have the fastest growth rate in the breathing circuits market, by circuit type, during the forecast period."

The breathing circuits market is segmented into single-limb breathing circuits and dual-limb breathing circuits, based on circuit type. Dual-limb breathing circuits are projected to account for the highest CAGR during the forecast period. Dual-limb breathing circuits are likely to witness a huge demand, as they offer numerous advantages for critical and specialized medical applications. One major factor is that they provide two distinct and controlled channels for inhalation and exhalation, which increases the efficiency of ventilation by preventing rebreathing of exhaled carbon dioxide. This would be very important in ICUs and OTs, where it would be important to correct management of gases in order to ensure patient safety and optimum respiratory support. Another advantage of dual-limb circuits is that accessories, like humidifiers, filters, and monitoring equipment, can be fitted to facilitate appropriate and comprehensive care for the patient. Added to this is the fact that these circuits can adapt to different patients and different medical interventions that further increase their applicability in healthcare.

"Asia Pacific: The fastest-growing region in breathing circuits market."

The worldwide market for breathing circuits is categorized into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. Notably, the Asia Pacific region is anticipated to experience the most substantial growth in the forecast period. The Asia Pacific region, a hub for medical tourism, is rapidly emerging as a leader in the market for medical procedures and devices. Growth in this market is driven by several factors, that include the increased investment and modernization in the health care infrastructure, which improves the availability as well as the quality of medical services. Rising patient population and occurrences of chronic respiratory diseases further fuel the demand. Moreover, high economic growth in developing countries, including China, India, and others, has led to increases in health care expenditures and the demand for more modern medical devices, including breathing circuits.

The break-up of the profile of primary participants in the breathing circuits market:

  • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
  • By Designation: C-level - 27%, D-level - 18%, and Others - 55%
  • By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America - 6%, and Middle East & Africa- 4%

The key players in this market are Dragerwerk AG & Co. KGaA (Germany), Medtronic (Ireland), Cardinal Health (US), Fisher & Paykel Healthcare Limited (New Zealand), ResMed (US), Ambu A/S (Denmark), GE Healthcare (US), ICU Medical, Inc. (US), Koninklijke Philips N.V. (Netherlands), Hamilton Medical (Switzerland), Medline Industries, LP (US), Forca Healthcare (India), Braun & Co. Limited (UK), Inspiration Healthcare Group PLC (UK), Besmed Health Business Corp. (Taiwan), Eakin Healthcare (UK), BOMIMED (Canada), Flexicare (Group) Limited (UK), Bio-Med Devices (US), Airlife (US), Mercury Medical (US), Intersurgical Ltd (UK), Fairmont Medical Products Pty Ltd. (Australia), Breas Medical AB (Sweden), and GPC Medical Ltd. (India).

Research Coverage:

This research report categorizes the breathing circuits market by usage (disposable breathing circuits and reusable breathing circuits), by patient type (adult patients and pediatric and neonatal patients), by circuit type (single-limb breathing circuits and dual-limb breathing circuits), by application (anesthesia, respiratory dysfunction, and other applications), by end user (hospitals, ambulatory surgical centers, clinics, and other end users), and region (North America, Europe, Asia Pacific, Latin America, the Middle East & Africa and GCC countries). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the breathing circuits market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. New product & service launches, and recent developments associated with the breathing circuits market. Competitive analysis of upcoming startups in the breathing circuits market ecosystem is covered in this report.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall breathing circuits market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Analysis of key drivers (growing prevalence of respiratory diseases, rising number of emergency cases globally, increasing number of surgical procedures, and technological advancements), opportunities (Growth opportunities in emerging economies), restraints (Unfavorable reimbursement scenario and high risk of infection associated with reusable breathing circuits), and challenges (environmental concerns related to single-use and non-biodegradable breathing circuits) influencing the growth of the breathing circuits market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the breathing circuits market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the breathing circuits market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the breathing circuits market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like Dragerwerk AG & Co. KGaA (Germany), Medtronic (Ireland), Cardinal Health (US), Fisher & Paykel Healthcare Limited (New Zealand), and ResMed (US).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 SEGMENTS CONSIDERED
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key secondary sources
      • 2.1.1.2 Key data from secondary sources
      • 2.1.1.3 Objectives of secondary research
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key primary sources
      • 2.1.2.2 Key data from primary sources
      • 2.1.2.3 Key industry insights
      • 2.1.2.4 Breakdown of primaries
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
      • 2.2.1.1 Company revenue estimation approach
      • 2.2.1.2 Company presentations and primary interviews
      • 2.2.1.3 Growth forecast
      • 2.2.1.4 CAGR projections
    • 2.2.2 TOP-DOWN APPROACH
  • 2.3 DATA TRIANGULATION
  • 2.4 MARKET SHARE ANALYSIS
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 GROWTH RATE ASSUMPTIONS
  • 2.7 RESEARCH LIMITATIONS
  • 2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 BREATHING CIRCUITS MARKET OVERVIEW
  • 4.2 BREATHING CIRCUITS MARKET, BY USAGE, 2024 VS. 2029
  • 4.3 BREATHING CIRCUITS MARKET, BY PATIENT TYPE, 2024 VS. 2029
  • 4.4 BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE, 2024 VS. 2029
  • 4.5 BREATHING CIRCUITS MARKET, BY APPLICATION, 2024 VS. 2029
  • 4.6 BREATHING CIRCUITS MARKET, BY END USER, 2024 VS. 2029
  • 4.7 BREATHING CIRCUITS MARKET: REGIONAL GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing prevalence of respiratory diseases
      • 5.2.1.2 Rising number of emergency cases globally
      • 5.2.1.3 Increasing number of surgical procedures
      • 5.2.1.4 Technological advancements
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Unfavorable reimbursement scenario
      • 5.2.2.2 High risk of infection associated with reusable breathing circuits
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growth opportunities in emerging economies
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Environmental concerns related to single-use and non-biodegradable breathing circuits
  • 5.3 PRICING ANALYSIS
  • 5.4 PATENT ANALYSIS
    • 5.4.1 LIST OF MAJOR PATENTS
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 SUPPLY CHAIN ANALYSIS
  • 5.7 TRADE ANALYSIS
    • 5.7.1 IMPORT DATA (HS CODE 901920)
    • 5.7.2 EXPORT DATA (HS CODE 901920)
  • 5.8 ECOSYSTEM ANALYSIS
    • 5.8.1 ROLE IN ECOSYSTEM
  • 5.9 PORTER'S FIVE FORCES ANALYSIS
    • 5.9.1 THREAT OF NEW ENTRANTS
    • 5.9.2 THREAT OF SUBSTITUTES
    • 5.9.3 BARGAINING POWER OF BUYERS
    • 5.9.4 BARGAINING POWER OF SUPPLIERS
    • 5.9.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.10 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.10.2 KEY BUYING CRITERIA
  • 5.11 REGULATORY ANALYSIS
    • 5.11.1 REGULATORY LANDSCAPE
      • 5.11.1.1 North America
        • 5.11.1.1.1 US
        • 5.11.1.1.2 Canada
      • 5.11.1.2 Europe
      • 5.11.1.3 Asia Pacific
        • 5.11.1.3.1 China
        • 5.11.1.3.2 Japan
        • 5.11.1.3.3 India
      • 5.11.1.4 Latin America
        • 5.11.1.4.1 Brazil
        • 5.11.1.4.2 Mexico
      • 5.11.1.5 Middle East
      • 5.11.1.6 Africa
    • 5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.12 TECHNOLOGY ANALYSIS
    • 5.12.1 KEY TECHNOLOGIES
      • 5.12.1.1 Single-limb breathing circuits
    • 5.12.2 COMPLEMENTARY TECHNOLOGIES
      • 5.12.2.1 Dual-limb breathing circuits
    • 5.12.3 ADJACENT TECHNOLOGIES
      • 5.12.3.1 Low dead space circuits
  • 5.13 KEY CONFERENCES AND EVENTS IN 2024-2025
  • 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.15 INVESTMENT AND FUNDING SCENARIO
  • 5.16 IMPACT OF AI/GEN AI ON BREATHING CIRCUITS MARKET
    • 5.16.1 KEY USE CASES

6 BREATHING CIRCUITS MARKET, BY USAGE

  • 6.1 INTRODUCTION
  • 6.2 DISPOSABLE BREATHING CIRCUITS
    • 6.2.1 GROWING EMPHASIS ON INFECTION CONTROL AND PATIENT SAFETY TO DRIVE MARKET
  • 6.3 REUSABLE BREATHING CIRCUITS
    • 6.3.1 COST-EFFECTIVENESS AND REDUCED ENVIRONMENTAL FOOTPRINT TO PROPEL MARKET GROWTH

7 BREATHING CIRCUITS MARKET, BY PATIENT TYPE

  • 7.1 INTRODUCTION
  • 7.2 ADULT PATIENTS
    • 7.2.1 INCREASING SURGICAL PROCEDURES AND GROWING PREVALENCE OF LIFESTYLE-RELATED DISEASES TO BOOST MARKET GROWTH
  • 7.3 PEDIATRIC AND NEONATAL PATIENTS
    • 7.3.1 INCREASING TIMELY INTERVENTION AND TREATMENT IN PEDIATRIC CARE TO FUEL MARKET GROWTH

8 BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE

  • 8.1 INTRODUCTION
  • 8.2 SINGLE-LIMB BREATHING CIRCUITS
    • 8.2.1 SIMPLE DESIGN AND EASE OF USE TO AID MARKET GROWTH
  • 8.3 DUAL-LIMB BREATHING CIRCUITS
    • 8.3.1 HIGH DEMAND FOR ADVANCED VENTILATION SOLUTIONS AND INCREASED PATIENT COMFORT TO SPUR MARKET GROWTH

9 BREATHING CIRCUITS MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
  • 9.2 ANESTHESIA
    • 9.2.1 INCREASING NUMBER OF SURGERIES AND MINIMALLY INVASIVE PROCEDURES TO AUGMENT MARKET GROWTH
  • 9.3 RESPIRATORY DYSFUNCTION
    • 9.3.1 RISING PREVALENCE OF CHRONIC PULMONARY DISEASES AND SLEEP APNEA TO FUEL MARKET GROWTH
  • 9.4 OTHER APPLICATIONS

10 BREATHING CIRCUITS MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 HOSPITALS
    • 10.2.1 INCREASING NUMBER OF HOSPITALS AND RISING GOVERNMENT HEALTHCARE INVESTMENTS TO SUPPORT MARKET GROWTH
  • 10.3 AMBULATORY SURGERY CENTERS
    • 10.3.1 FOCUS ON COST-EFFECTIVE AND IMPROVED PATIENT EXPERIENCE TO DRIVE MARKET
  • 10.4 CLINICS
    • 10.4.1 RISING PREVALENCE OF TARGET DISEASES TO SUPPORT MARKET GROWTH
  • 10.5 OTHER END USERS

11 BREATHING CIRCUITS MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 11.2.2 US
      • 11.2.2.1 US to dominate North American breathing circuits market during study period
    • 11.2.3 CANADA
      • 11.2.3.1 High geriatric population and improved healthcare infrastructure to propel market growth
  • 11.3 EUROPE
    • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 11.3.2 GERMANY
      • 11.3.2.1 High healthcare spending and favorable government policies to favor market growth
    • 11.3.3 FRANCE
      • 11.3.3.1 Advanced healthcare system and increased number of surgeries to augment market growth
    • 11.3.4 UK
      • 11.3.4.1 Rising geriatric population and increasing initiatives by public and private organizations to aid market growth
    • 11.3.5 ITALY
      • 11.3.5.1 Improved quality of medical care and high geriatric population to spur market growth
    • 11.3.6 SPAIN
      • 11.3.6.1 Increased incidence of chronic diseases and improved healthcare infrastructure to drive demand
    • 11.3.7 REST OF EUROPE
  • 11.4 ASIA PACIFIC
    • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 11.4.2 JAPAN
      • 11.4.2.1 Presence of universal healthcare reimbursement policy and high geriatric population to drive market
    • 11.4.3 CHINA
      • 11.4.3.1 Increasing number of hospitals and growing public access to modern healthcare to fuel market growth
    • 11.4.4 INDIA
      • 11.4.4.1 Large patient population and developed healthcare sector to boost market growth
    • 11.4.5 AUSTRALIA
      • 11.4.5.1 Increasing prevalence of chronic respiratory diseases to fuel market
    • 11.4.6 SOUTH KOREA
      • 11.4.6.1 Increasing private hospitals and growing medical tourism to support market growth
    • 11.4.7 REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 11.5.2 BRAZIL
      • 11.5.2.1 Developed public health systems and improved healthcare infrastructure to favor market growth
    • 11.5.3 MEXICO
      • 11.5.3.1 Modern healthcare infrastructure and availability of advanced surgical techniques to augment market growth
    • 11.5.4 REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 DEVELOPED HEALTHCARE INFRASTRUCTURE AND FAVORABLE GOVERNMENT HEALTH POLICIES TO PROPEL MARKET
    • 11.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 11.7 GCC COUNTRIES
    • 11.7.1 INCREASING GOVERNMENT HEALTHCARE SPENDING AND GROWING MEDICAL TOURISM TO AID MARKET GROWTH
    • 11.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

12 COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
  • 12.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN BREATHING CIRCUITS MARKET
  • 12.3 REVENUE ANALYSIS, 2021-2023
  • 12.4 MARKET SHARE ANALYSIS, 2023
  • 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 12.5.1 STARS
    • 12.5.2 EMERGING LEADERS
    • 12.5.3 PERVASIVE PLAYERS
    • 12.5.4 PARTICIPANTS
    • 12.5.5 COMPANY FOOTPRINT, KEY PLAYERS, 2023
      • 12.5.5.1 Company footprint
      • 12.5.5.2 Usage footprint
      • 12.5.5.3 Application footprint
      • 12.5.5.4 Region footprint
  • 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 12.6.1 PROGRESSIVE COMPANIES
    • 12.6.2 RESPONSIVE COMPANIES
    • 12.6.3 DYNAMIC COMPANIES
    • 12.6.4 STARTING BLOCKS
    • 12.6.5 COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS, 2023
  • 12.7 COMPANY VALUATION AND FINANCIAL METRICS
  • 12.8 BRAND/PRODUCT COMPARISON
  • 12.9 COMPETITIVE SCENARIO
    • 12.9.1 PRODUCT LAUNCHES
    • 12.9.2 DEALS

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
    • 13.1.1 DRAGERWERK AG & CO. KGAA
      • 13.1.1.1 Business overview
      • 13.1.1.2 Products offered
      • 13.1.1.3 Recent developments
        • 13.1.1.3.1 Product launches
        • 13.1.1.3.2 Deals
      • 13.1.1.4 MnM view
        • 13.1.1.4.1 Key strengths
        • 13.1.1.4.2 Strategic choices
        • 13.1.1.4.3 Weaknesses and competitive threats
    • 13.1.2 MEDTRONIC
      • 13.1.2.1 Business overview
      • 13.1.2.2 Products offered
      • 13.1.2.3 Recent developments
        • 13.1.2.3.1 Deals
      • 13.1.2.4 MnM view
        • 13.1.2.4.1 Key strengths
        • 13.1.2.4.2 Strategic choices
        • 13.1.2.4.3 Weaknesses and competitive threats
    • 13.1.3 CARDINAL HEALTH
      • 13.1.3.1 Business overview
      • 13.1.3.2 Products offered
      • 13.1.3.3 Recent developments
        • 13.1.3.3.1 Expansions
      • 13.1.3.4 MnM view
        • 13.1.3.4.1 Key strengths
        • 13.1.3.4.2 Strategic choices
        • 13.1.3.4.3 Weaknesses and competitive threats
    • 13.1.4 FISHER & PAYKEL HEALTHCARE LIMITED
      • 13.1.4.1 Business overview
      • 13.1.4.2 Products offered
      • 13.1.4.3 Recent developments
        • 13.1.4.3.1 Expansions
      • 13.1.4.4 MnM view
        • 13.1.4.4.1 Key strengths
        • 13.1.4.4.2 Strategic choices
        • 13.1.4.4.3 Weaknesses and competitive threats
    • 13.1.5 RESMED
      • 13.1.5.1 Business overview
      • 13.1.5.2 Products offered
      • 13.1.5.3 Recent developments
        • 13.1.5.3.1 Expansions
      • 13.1.5.4 MnM view
        • 13.1.5.4.1 Key strengths
        • 13.1.5.4.2 Strategic choices
        • 13.1.5.4.3 Weaknesses and competitive threats
    • 13.1.6 AMBU A/S
      • 13.1.6.1 Business overview
      • 13.1.6.2 Products offered
      • 13.1.6.3 Recent developments
        • 13.1.6.3.1 Expansions
    • 13.1.7 GE HEALTHCARE
      • 13.1.7.1 Business overview
      • 13.1.7.2 Products offered
      • 13.1.7.3 Recent developments
        • 13.1.7.3.1 Deals
        • 13.1.7.3.2 Expansions
    • 13.1.8 KONINKLIJKE PHILIPS N.V.
      • 13.1.8.1 Business overview
      • 13.1.8.2 Products offered
      • 13.1.8.3 Recent developments
        • 13.1.8.3.1 Deals
    • 13.1.9 ICU MEDICAL, INC.
      • 13.1.9.1 Business overview
      • 13.1.9.2 Products offered
      • 13.1.9.3 Recent developments
        • 13.1.9.3.1 Deals
    • 13.1.10 HAMILTON MEDICAL
      • 13.1.10.1 Business overview
      • 13.1.10.2 Products offered
    • 13.1.11 MEDLINE INDUSTRIES, LP
      • 13.1.11.1 Business overview
      • 13.1.11.2 Products offered
      • 13.1.11.3 Recent developments
        • 13.1.11.3.1 Deals
        • 13.1.11.3.2 Expansions
  • 13.2 OTHER PLAYERS
    • 13.2.1 FORCA HEALTHCARE
    • 13.2.2 BRAUN & CO. LIMITED
    • 13.2.3 INSPIRATION HEALTHCARE GROUP PLC
    • 13.2.4 BESMED HEALTH BUSINESS CORP.
    • 13.2.5 EAKIN HEALTHCARE
    • 13.2.6 BOMIMED
    • 13.2.7 FLEXICARE (GROUP) LIMITED
    • 13.2.8 BIO-MED DEVICES
    • 13.2.9 AIRLIFE
    • 13.2.10 MERCURY MEDICAL
    • 13.2.11 INTERSURGICAL LTD.
    • 13.2.12 FAIRMONT MEDICAL PRODUCTS PTY LTD.
    • 13.2.13 BREAS MEDICAL AB
    • 13.2.14 GPC MEDICAL LTD.

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제